Filing Details

Accession Number:
0001209191-22-053967
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-18 16:25:25
Reporting Period:
2022-10-14
Accepted Time:
2022-10-18 16:25:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367920 Concert Pharmaceuticals Inc. CNCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1171527 Barton Peter Hutt C/O Concert Pharmaceuticals, Inc.
65 Hayden Avenue, Suite 3000N
Lexington MA 02421
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-14 3,539 $2.88 33,027 No 4 M Direct
Common Stock Disposition 2022-10-14 3,539 $6.09 29,488 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-10-14 3,539 $0.00 3,539 $2.88
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2022-11-12 No 4 M Direct
Footnotes
  1. This option is fully vested.